WallStreetZenWallStreetZen

NASDAQ: BLLN
Billiontoone Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for BLLN

Based on 6 analysts offering 12 month price targets for Billiontoone Inc

Min Forecast
$110.00+23.18%
Avg Forecast
$137.83+54.35%
Max Forecast
$160.00+79.17%

Should I buy or sell BLLN stock?

Based on 6 analysts offering ratings for Billiontoone Inc.

Strong Buy
Strong Buy
4 analysts 66.67%
Buy
0 analysts 0%
Hold
2 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although BLLN's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates BLLN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their BLLN stock forecasts and price targets.

BLLN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-10
lockedlocked$00.00+00.00%2025-12-10
lockedlocked$00.00+00.00%2025-12-01
lockedlocked$00.00+00.00%2025-12-01
lockedlocked$00.00+00.00%2025-12-01
Jefferies
Top 16%
85
HoldInitiates Coverage On$117.00+31.02%2025-12-01

1 of 1

Forecast return on equity

Is BLLN forecast to generate an efficient return?

Company
-16.76%
Industry
10.29%
Market
339.08%
BLLN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BLLN forecast to generate an efficient return on assets?

Company
12.25%
Industry
11.91%
BLLN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BLLN earnings per share forecast

What is BLLN's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$0.17
Avg 2 year Forecast
$0.27
Avg 3 year Forecast
$0.88

BLLN revenue forecast

What is BLLN's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$301.8M
Avg 2 year Forecast
$410.1M
Avg 3 year Forecast
$550.0M

BLLN vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
BLLN$89.30$137.83+54.35%Strong Buy
GRAL$91.59$105.00+14.64%Strong Buy
SHC$17.70$18.00+1.69%Buy
RDNT$73.15$84.50+15.52%Strong Buy
TWST$33.05$40.67+23.05%Strong Buy
View Top Diagnostic & Research Stocks

Billiontoone Stock Forecast FAQ

Is Billiontoone Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 6 Wall Street analysts covering (NASDAQ: BLLN) stock is to Strong Buy BLLN stock.

Out of 6 analysts, 4 (66.67%) are recommending BLLN as a Strong Buy, 0 (0%) are recommending BLLN as a Buy, 2 (33.33%) are recommending BLLN as a Hold, 0 (0%) are recommending BLLN as a Sell, and 0 (0%) are recommending BLLN as a Strong Sell.

If you're new to stock investing, here's how to buy Billiontoone stock.

What is BLLN's earnings growth forecast for 2025-2027?

(NASDAQ: BLLN) Billiontoone's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 20.48%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 103.89%.

Billiontoone's earnings in 2025 is N/A.On average, 9 Wall Street analysts forecast BLLN's earnings for 2025 to be $7,661,690, with the lowest BLLN earnings forecast at -$1,345,602, and the highest BLLN earnings forecast at $23,067,455. On average, 9 Wall Street analysts forecast BLLN's earnings for 2026 to be $12,357,565, with the lowest BLLN earnings forecast at $0, and the highest BLLN earnings forecast at $33,786,499.

In 2027, BLLN is forecast to generate $40,134,626 in earnings, with the lowest earnings forecast at $17,044,286 and the highest earnings forecast at $89,290,274.

What is BLLN's revenue growth forecast for 2025-2027?

(NASDAQ: BLLN) Billiontoone's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.93%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.76%.

Billiontoone's revenue in 2025 is N/A.On average, 9 Wall Street analysts forecast BLLN's revenue for 2025 to be $13,813,011,768, with the lowest BLLN revenue forecast at $13,128,768,806, and the highest BLLN revenue forecast at $14,358,117,700. On average, 9 Wall Street analysts forecast BLLN's revenue for 2026 to be $18,768,395,413, with the lowest BLLN revenue forecast at $17,089,139,609, and the highest BLLN revenue forecast at $22,266,044,052.

In 2027, BLLN is forecast to generate $25,173,275,688 in revenue, with the lowest revenue forecast at $22,682,539,768 and the highest revenue forecast at $30,341,941,754.

What is BLLN's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: BLLN) forecast ROA is 12.25%, which is higher than the forecast US Diagnostics & Research industry average of 11.91%.

What is BLLN's Price Target?

According to 6 Wall Street analysts that have issued a 1 year BLLN price target, the average BLLN price target is $137.83, with the highest BLLN stock price forecast at $160.00 and the lowest BLLN stock price forecast at $110.00.

On average, Wall Street analysts predict that Billiontoone's share price could reach $137.83 by Dec 10, 2026. The average Billiontoone stock price prediction forecasts a potential upside of 54.35% from the current BLLN share price of $89.30.

What is BLLN's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: BLLN) Billiontoone's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that BLLN's EPS will be $0.17 for 2025, with the lowest EPS forecast at -$0.03, and the highest EPS forecast at $0.50. On average, analysts forecast that BLLN's EPS will be $0.27 for 2026, with the lowest EPS forecast at $0.00, and the highest EPS forecast at $0.74. In 2027, BLLN's EPS is forecast to hit $0.88 (min: $0.37, max: $1.95).

What is BLLN's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: BLLN) forecast ROE is -16.76%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.